Who is the CEO of Neurotech International Limited?

The CEO of Neurotech International Limited is Anthony Filippis.

What industry does Neurotech International Limited belong to?

Neurotech International Limited operates in the Medical - Devices industry within the Healthcare sector.

Where is Neurotech International Limited headquartered?

Neurotech International Limited is headquartered at 145 Stirling Highway, Nedlands, WA, 6009, AU.

What is the IPO date of Neurotech International Limited?

Neurotech International Limited went public on November 3, 2016.

How many employees does Neurotech International Limited have?

Neurotech International Limited has approximately 18 full-time employees.

Neurotech International Limited

NTI.AX•ASX

Healthcare

Medical - Devices

A$0.02

A$-0.00(-15.79%)

Neurotech International Limited (NTI.AX) Company Profile & Overview

Explore Neurotech International Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Neurotech International Limited (NTI.AX) Company Profile & Overview

Neurotech International Limited, together with its subsidiaries, engages in the research, design, development, and manufacture of medical devices and solutions in Australia. The company is focused on development and commercializing Mente platform, a platform technology to monitor and play role in home-based therapies. Its product includes Mente Autism for the diagnosis and treatment of autism. It also engages in executing of medical research projects; and developing of technological devices. The company was incorporated in 2016 and is based in Nedlands, Australia.

SectorHealthcare

IndustryMedical - Devices

CEOAnthony Filippis

Contact Information

https://www.neurotechinternational.com

61 8 9389 3130

145 Stirling Highway, Nedlands, WA, 6009

Company Facts

18 Employees

IPO DateNov 3, 2016

CountryAU

Actively Trading

Frequently Asked Questions

;